Tetrahydrocannabivarin may be beneficial in typ 2 diabetes according to a clinical study
The plant cannabinoid THCV (tetrahydrocannabivarin) decreases glucose levels and may have further beneficial effects in patients with type 2 diabetes. This is the result of research by scientists from Nottingham, London and Oxford in the…